which are held as short-term investments in non-marketable securities at amortized cost and the related earnings on those investments. Return to table 3. Reported at fair value. Return to table 4. Reported at principal amount outstanding, net of allowance including interest. Return to table 5. Reported at amortized cost. Return to table 6. Reported at principal amount outstanding. Return to table Investments held by MLF are subject to review each reporting period to identify indications of other-than-temporary impairment, and no impairments were indicated as of March 31, 2022. TALF II loans and Main Street loan participations are evaluated for impairment in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 310 and Topic 450. No impairments were indicated for loans, and there were no loans in non-accrual status extended by TALF II as of March 31, 2022. Main Street's allowance for loan losses consists of specific allowances for impaired loan participations and a general allowance for all other loan participations, collectively reflecting management's estimate of probable loan losses inherent in the loan portfolio at reporting date. The principal exposure of loan participations in non-accrual status as of March 31, 2022, was $3,337 million. The evaluation of loan participations purchased